The FNP Review

The 4 High-Yield Pharmacology Concepts Every FNP Student Must Master for Boards

Pharmacology · 3 min read · August 28, 2026

Demystifying FNP Board Pharmacology

Pharmacology makes up a significant portion of both the AANP and ANCC family nurse practitioner certification exams. Yet, many students feel overwhelmed by the sheer volume of medications, mechanisms of action, and side effect profiles. The secret to conquering board pharmacology isn't memorizing every drug on the market; it is understanding the high-yield classes, first-line agents, and critical safety warnings that frequently appear on the exam. Let's break down four core pharmacological areas you must know before exam day.

1. Cardiovascular Medications: ACE Inhibitors, ARBs, and Safety First

Cardiovascular pharmacology is a staple of board exams. You are guaranteed to see questions regarding hypertension management in specific patient populations.

  • ACE Inhibitors (e.g., Lisinopril) and ARBs (e.g., Losartan): These are first-line choices for hypertension, especially in patients with diabetes mellitus, chronic kidney disease, or post-myocardial infarction.
  • Key Side Effects: ACE inhibitors are famously known for causing a dry, persistent cough due to an accumulation of bradykinin. If a patient develops this cough, switching to an ARB is the standard clinical response.
  • Board Clinical Pearl: ACE inhibitors and ARBs are absolute contraindications in pregnancy (Category X) because they cause renal failure and oligohydramnios in the second and third trimesters. Furthermore, never combine an ACE inhibitor with an ARB or a direct renin inhibitor due to the high risk of hyperkalemia, hypotension, and renal impairment.

2. Endocrine Management: Antidiabetic Agents and Hypoglycemic Risks

Managing type 2 diabetes safely is another major focus for board questions. You need to know not just what lowers blood glucose, but what protects end-organs and carries specific risks.

  • Metformin: This remains the undisputed first-line oral agent for type 2 diabetes. Remember its primary black box warning: lactic acidosis. It must be temporarily discontinued before any radiologic procedure using iodinated contrast media to prevent acute kidney injury.
  • GLP-1 Receptor Agonists (e.g., Dulaglutide) and SGLT2 Inhibitors (e.g., Empagliflozin): Expect questions on these due to their proven cardiovascular and renal benefits. SGLT2 inhibitors reduce heart failure hospitalizations and slow kidney disease progression, but watch out for increased risks of mycotic genital infections and euglycemic diabetic ketoacidosis.
  • Board Clinical Pearl: Thiazolidinediones (TZDs like pioglitazone) carry a black box warning for causing or exacerbating congestive heart failure. Do not prescribe TZDs to patients with NYHA Class III or IV heart failure.

3. Antimicrobial Stewardship: Choosing the Right Antibiotic Safely

Infectious disease scenarios test your ability to match the correct pathogen with the safest, most effective antimicrobial while avoiding adverse reactions.

  • Macrolides (e.g., Azithromycin): Frequently used for community-acquired pneumonia in outpatient settings, but always keep QT prolongation in mind.
  • Fluoroquinolones (e.g., Ciprofloxacin, Levofloxacin): Excellent broad-spectrum coverage, but they carry a prominent black box warning for tendonitis and tendon rupture (especially the Achilles tendon), as well as exacerbation of myasthenia gravis.
  • Board Clinical Pearl: Always screen female patients of childbearing age for pregnancy when prescribing tetracyclines (like doxycycline) or fluoroquinolones, as both classes pose significant fetal risks (e.g., bone growth suppression and tooth discoloration).

4. Mental Health and Neuromodulation: Antidepressants and Withdrawal

Psychopharmacology questions often center around safe initiation, switching, and discontinuation of selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs).

  • SSRIs (e.g., Sertraline, Citalopram): First-line treatment for depression and generalized anxiety disorder.
  • Serotonin Syndrome: A life-threatening emergency caused by overactivation of central serotonin receptors, typically seen when combining two or more serotonergic agents (e.g., an SSRI and a MAOI, or an SSRI and tramadol). Symptoms include hyperreflexia, myoclonus, diaphoresis, agitation, and shivering.
  • Board Clinical Pearl: Never stop antidepressants abruptly. Taper them slowly over several weeks to avoid severe antidepressant discontinuation syndrome, characterized by flu-like symptoms, dizziness, and vivid, electric-shock-like sensations ("brain zaps").

You have already put in the hard work required to reach this stage of your FNP journey. Trust your clinical intuition, focus on core safety mechanisms, and remember that board questions are designed to test safe, competent entry-level practice. Visit thefnpreview.com today to access our comprehensive Qbank and take the next step toward passing your boards with confidence.